Skip to Content

CNN – Health

Novo Nordisk expects Wegovy starter dose restrictions to persist into 2024, longer than previously forecast

By Meg Tirrell, CNN (CNN) — Citing “unprecedented demand,” drugmaker Novo Nordisk said Thursday it expects supply restrictions on starter doses of the weight loss medicine Wegovy to persist into 2024, several months beyond its previous prediction. The company is prioritizing higher, or so-called maintenance, doses of the medicine so that patients who have already

Continue Reading

Nearly all hospital pharmacists say drug shortages are negatively impacting care; a third say impacts are ‘critical’

By Deidre McPhillips, CNN (CNN) — As drug shortages near record levels in the United States, a new survey shows how widespread — and serious — the effects are. About 99% of health care system pharmacists who were surveyed — the vast majority of whom work in hospitals — say that they are experiencing drug shortages, including

Continue Reading

Deaths, disabilities from heart problems related to air pollution are on the rise, study finds

By Jen Christensen, CNN (CNN) — The number of people killed or disabled by certain heart problems caused by exposure to air pollution has risen significantly since 1990: 31% worldwide, according to a study published Wednesday in the Journal of the American Heart Association. Particle pollution is specifically to blame, the researchers say. Also called

Continue Reading

Drugmakers say they’re adjusting their ‘thinking on price’ of first postpartum depression pill approved in the US

By Jacqueline Howard, CNN (CNN) — Drugmakers Sage Therapeutics and Biogen are still ironing out how much their newly approved postpartum depression medication, zuranolone, will cost once it’s made commercially available in the United States this year. Zuranolone, sold under the brand name Zurzuvae, is expected to launch in the fourth quarter of 2023, and the companies’ goal is for the medication

Continue Reading